Asymmetric synthesis of piperazic acid and derivatives thereof
AssigneeVertex Pharmaceuticals Incorporated
InventorsAndrea L. C. Robidoux, Siro Serafini, Petra Dieterich, Stefania Leonardi, John Stibbard
Life of this patent
Estimating the term…
Loading patent…
AssigneeVertex Pharmaceuticals Incorporated
InventorsAndrea L. C. Robidoux, Siro Serafini, Petra Dieterich, Stefania Leonardi, John Stibbard
Estimating the term…
This invention provides a concise, asymmetric synthesis of piperazic acid and derivatives thereof, whereby either the (3S)- or (3R)-enantiomeric form may be obtained with high optical purity. (3S)-piperazic acid is derived from D-glutamic acid through an (R)-2,5-dihydroxyvalerate ester intermediate. After the hydroxy groups are converted to suitable leaving groups, such as mesylates, the ester is treated with a bis-protected hydrazine to provide the desired (3S)-piperazic acid derivative. The (3R) enantiomer of piperazic acid may be similarly obtained starting with L-glutamic acid. The method may also be used to obtain piperazic acid derivatives that have moderate optical purity or are racemic. By this method, piperazic acid derivatives may be obtained that are useful as intermediates for pharmacologically active compounds. For example, certain intermediates of this invention are useful for preparing caspase inhibitors, particularly inhibitors of ICE, through additional steps known in the art.
A method for preparing a compound having the formula:
A method for preparing a compound of formula IV:
A method for enhancing the %ee of a first enantiomeric mixture of a compound of formula IV
A method for preparing an enantiomerically enriched compound of formula IV, said method comprising the steps of:
A compound of formula B, C, or D:
Dependencies are inferred from the claim text.